Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Gaza Israel war Conflict in Sudan Surgery & trauma care

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Palestine Sudan South Sudan

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
Access Campaign

We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
559 Results
 
msf-placeholder
Global

MSF study shows good outcomes for second-line AIDS treatment in resource-poor settings

But access to needed newer medicines remains an alarming problem. Regimens that consist of newer medicines can cost between 10 and 50 times more than today's standard first-line therapy. Beyond price, many newer medicines are marketed under monopoly-like conditions, as was the case for first-line drugs in the late 1990s. Press Release - 1 Mar 2007
 
msf-placeholder
Access to medicines

Former Swiss president joins call for Novartis to drop its case in India

Former President of the Swiss Confederation Ruth Dreifuss voiced her concern today about the impact Swiss pharmaceutical company Novartis' legal challenge against the Indian government could have on access to essential medicines across the globe. Project Update - 16 Feb 2007
 
msf-placeholder
India

Church leaders call on Novartis to drop legal case in India

The decision in this case will affect access to thousands of other medicines in India, including anti-retroviral (ARV) medicines to treat HIV. Generic manufacture of older, first-line ARVs has made prices affordable, but as resistance and adverse reactions develop there is a great need for access to newer second-line drugs that are still very expensive.
SIGN THE PETITION
click here Project Update - 16 Feb 2007
 
msf-placeholder
Guatemala

In Guatemala, the Ministry of Health is to take over MSF's treatment of HIV patients in Coatepec

"For us at MSF, this transfer of responsibility to the public health authorities is a very positive sign," said Dr. Markus Lüthi, MSF's Medical Coordinator in Guatemala.
MSF will monitor to ensure uninterrupted supplies of antiretrovirals Press Release - 14 Feb 2007
 
msf-placeholder
Global

People are not getting the treatment they need to stay alive - newer AIDS drugs are unaffordable and unavailable

"First, treatment costs are going to rise massively in the coming years unless something is done about high drug prices. Second, we cannot rely on pharmaceutical companies to solve this problem. We need drastic changes in strategy," said Dr. Tido von Schoen-Angerer, Director of MSF's Campaign for Access to Essential Medicines. Press Release - 29 Nov 2006
 
msf-placeholder
South Africa

The steady danger of stock-outs: MSF's experience accessing TDF in South Africa

We are increasingly concerned that after nearly three years of experience importing TDF, we have still not been able to establish a reliable importation system, nor is the drug registered here yet. Project Update - 29 Nov 2006
 
msf-placeholder
Thailand

Unaffordable and unavailable: Newer ARVs in Thailand

The new heat-stable version of lopinavir/ritonavir (LPV/r) remains too expensive and is not yet registered for use in Thailand. Project Update - 29 Nov 2006
 
msf-placeholder
Guatemala

Global Fund and Guatemalan government urged to commit resources to ensure broader HIV/AIDS treatment and lower drug prices

The Global Fund should encourage Guatemala and other middle-income countries to take advantage of World Trade Organization mechanisms, as defined in the 2001 Doha Declaration, to purchase the most effective medicines at the best prices. Press Release - 3 Nov 2006
 
msf-placeholder
South Africa

Lusikisiki celebrates 2,200 people on ARV treatment at hand-over ceremony

HIV/AIDS partnership celebration in the Eastern Cape, South Africa: "Implementing comprehensive HIV services in Lusikisiki has needed many 'out-of-the-box' solutions to overcome the challenges we faced," said Dr Hermann Reuter, MSF project co-ordinator. "The only way to make this programme sustainable and replicable is to ensure that those solutions are urgently translated into policy changes at National and Provincial levels." Press Release - 12 Oct 2006
 
msf-placeholder

Groups urge rapid review of Canada's law on generic medicines for export

Canadian government must put patients at the heart of legislation. Press Release - 18 Aug 2006
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more